On Monday 13 July, the Academy hosted a Fellows’ discussion dinner as part of its contribution to the Government’s accelerated access review, which aims to “speed up access to innovative drugs, devices and diagnostics for NHS patients”.
The independent review, announced by the George Freeman MP, the Minister for Life Sciences, last November, will make recommendations to Government on reforms to the pathways for the development, assessment, and adoption of innovative medicines and medical products. It will focus on three main areas of potential reform: regulation, reimbursement and uptake. The review is being chaired by Sir Hugh Taylor, Chair of Guy's and St. Thomas' NHS Foundation Trust, with support provided by the Government’s Office for Life Sciences.
This week’s dinner, co-chaired by Professor Sir John Tooke PMedSci, President of the Academy of Medical Sciences, and Professor Sir John Bell FRS HonFREng FMedSci, Chair of the review’s external advisory group (EAG), gave Fellows and other invited guests the opportunity to identify key priority areas for consideration under the review and suggest practical improvements and solutions. Attendees included Fellows drawn from regulatory agencies, the life sciences industry, academia and the third sector, as well as two members of the review’s EAG and a representative from the Office for Life Sciences.
Topics of discussion included the need to focus efforts on developing, implementing and rewarding the use of effective (as opposed to all) innovation, the importance of IT and data in enabling evaluation to occur at all stages of adoption, and the need for recommendations to acknowledge the global context in which the life sciences industry operates.
A note of the dinner is available here. The Academy will continue to engage with the review team and the EAG over the coming months.